Cristian Muresanu

Mr. Cristian Muresanu

Ecology, Taxonomy and Nature Conservation, Institute of Biology Bucharest of Romanian Academy, Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Pharmacological Research
Verified
Journal Article
Closed access
MKMagdalena Koszewicz
Magdalena Koszewicz
JJJoanna Jaroch
Joanna Jaroch
ABAnna Brzecka-Bonnaud
Anna Brzecka-Bonnaud
MEMaria Ejma
Maria Ejma
SBSlawomir Budrewicz
Slawomir Budrewicz
Gjumrakch AlievGjumrakch Aliev
Gjumrakch Aliev

1 May 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MMMarta Makara-Studzinska
Marta Makara-Studzinska
SSSiva G. Somasundaram
Siva G. Somasundaram
JHJoanna Halicka
Joanna Halicka
AMAgata Madej
Agata Madej
Jerzy LeszekJerzy Leszek
Jerzy Leszek
Gjumrakch AlievGjumrakch Aliev
Gjumrakch Aliev
: A number of elderly patients commit suicide due to the interaction of various factors, including, for example, feelings of loneliness, financial distress, alcohol abuse, chronic pain, progressive diseases, and personality disorders. The data from the EU countries with the highest rates of suicide and suicide attempts among people over 55 years of age warrant the consideration of new approaches to address this social problem.Methods: PubMed and other databases, including Polish National data, were used for the analyses.Results: The average European suicide-attempt rate is 18 per 100 thousand inhabitants. More cases of suicides were reported among those over 55 years of age. Suicide attempts from the year 2012 to 2014 and deaths in 2012 have been reviewed. The risk factors involved in these events, such as depression and social situations including loneliness, health condition, etc., have been discussed to suggest a plausible preventative approach for this important elderly problem.Conclusion: The psychophysiology of elderly persons affected by retirement, socio-economic changes, limited personal autonomy, loneliness, lack of support by the family, and diseases ultimately may lead elderly patients to commit suicide. Thus, financial freedom, family support (respect, love, and care), proper medications, psychological and psychiatric interventions may help the elderly avoid suicidal thoughts and prevent attempts.

Verified
Journal Article
Open access
PDF file
Cristian MuresanuCristian Muresanu
Cristian Muresanu
SSSiva G. Somasundaram
Siva G. Somasundaram
SVSergey V. Vissarionov
Sergey V. Vissarionov
LSLuis Fernando Torres Solis
Luis Fernando Torres Solis
AHArturo Solis Herrera
Arturo Solis Herrera
Gjumrakch AlievGjumrakch Aliev
Gjumrakch Aliev
In this review, we propose a holistic approach to understanding cancer as a metabolic disease. Our search for relevant studies in medical databases concludes that cancer cells do not evolve directly from normal healthy cells. We hypothesize that aberrant DNA damage accumulates over time—avoiding the natural DNA controls that otherwise repair or replace the rapidly replicating cells. DNA damage starts to accumulate in non-replicating cells, leading to senescence and aging. DNA damage is linked with genetic and epigenetic factors, but the development of cancer is favored by telomerase activity. Evidence indicates that telomere length is affected by chronic inflammations, alterations of mitochondrial DNA, and various environmental factors. Emotional stress also influences telomere length. Chronic inflammation can cause oxidative DNA damage. Oxidative stress, in turn, can trigger mitochondrial changes, which ultimately alter nuclear gene expression. This vicious cycle has led several scientists to view cancer as a metabolic disease. We have proposed complex personalized treatments that seek to correct multiple changes simultaneously using a psychological approach to reduce chronic stress, immune checkpoint therapy with reduced doses of chemo and radiotherapy, minimal surgical intervention, if any, and mitochondrial metabolic reprogramming protocols supplemented by intermittent fasting and personalized dietary plans without interfering with the other therapies.

19 April 2022 in DNA and Cell Biology
Verified
Journal Article
Closed access
Cristian MuresanuCristian Muresanu
Cristian Muresanu
SKSergei Khalchitsky
Sergei Khalchitsky
We present an integrative understanding of cancer as a metabolic multifactorial, multistage disease. We focus on underlying genetics–environmental interactions, evidenced by telomere changes. A range of genetic and epigenetic factors, including physical agents and predisposing factors such as diet and lifestyle are included. We present a structured model of the causes of cancer, methods of investigations, approaches to cancer prevention, and polypharmaceutical multidisciplinary complex treatment within a framework of personalized medicine. We searched PubMed, National Cancer Institute online, and other databases for publications regarding causes of cancer, reports of novel mitochondrial reprogramming, epigenetic, and telomerase therapies and state-of-the-art investigations. We focused on multistep treatment protocols to enhance early detection of cancer, and elimination or neutralization of the causes and factors associated with cancer formation and progression. Our aim is to suggest a model therapeutic protocol that incorporates the patient's genome, metabolism, and immune system status; stage of tumor development; and comorbidity(ies), if any. Investigation and treatment of cancer is a challenge that requires further holistic studies that improve the quality of life and survival rates, but are most likely to aid prevention.

5 October 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
VTVadim V. Tarasov
Vadim V. Tarasov
NINikolay N. Ivanets
Nikolay N. Ivanets
ASAndrey A. Svistunov
Andrey A. Svistunov
VCVladimir N. Chubarev
Vladimir N. Chubarev
MKMarina A. Kinkulkina
Marina A. Kinkulkina
Gjumrakch AlievGjumrakch Aliev
Gjumrakch Aliev
Background: This review summarizes recent findings in molecular biology and neuroimaging and their applicability to the classification and identification of depression. We discuss whether there is reliable evidence that could become a basis for biomarkers or subtyping that may enhance our understanding of the biological foundations of depression and may be useful for clinical practice with respect to diagnosis and prognosis as well as the selection of treatments. Objective: The purpose of this investigation is to present molecular mechanisms that contribute to different origins of depressions that could prove useful in daily psychiatric clinic based practices. Method: The authors analyzed and summarized electronic publications available via PubMed, Science Direct, Google Scholar, and Scopus. Results: The introduction of molecular diagnostics methods into medical practice is a promising method to improve the accuracy of the diagnosis of depression in clinical settings. The literature analysis revealed structural changes in some areas of the brain, its neuroplasticity, as well as changes at the molecular, epigenetic, and genetic levels. However, there are no current reliable biomarkers for differential diagnosis of the types and subtypes of depression. Conclusion: Major depressive disorder is a biologically and genetically heterogeneous disorder. Given its complexity, subtyping is worthwhile to identify biological bases of conditions. The literature review provides ample findings that reveal possible underlying biological mechanisms associated with atypical and melancholic depression. Additional, focused research should be continued with respect to the molecular and genetic biology of different types of depression. There already are promising findings, but additional research to define biologically based depressive subtypes is needed and worthwhile.

12 June 2026 in Toxics
Verified
Journal Article
Open access
PDF file
CLCodruta Lencu
Codruta Lencu
Teodora AlexescuTeodora Alexescu
Teodora Alexescu
Cristian MuresanuCristian Muresanu
Cristian Muresanu
AGAndreea-Cezara Gerdanovics
Andreea-Cezara Gerdanovics
MMMircea Vasile Milaciu
Mircea Vasile Milaciu
Dana IancuDana Iancu
Dana Iancu
Endocrine-disrupting chemicals (EDCs) are a heterogeneous group of exogenous compounds capable of interfering with hormonal homeostasis and endocrine-regulated physiological processes. Their widespread occurrence in food, water, air, consumer products and industrial materials has raised increasing concern regarding their contribution to chronic disease burden. This review synthesizes current evidence on the exposure characteristics, molecular mechanisms, health effects, and prevention strategies related to major EDC classes, including bisphenol A and phthalates, dioxins and polychlorinated biphenyls, per- and polyfluoroalkyl substances, pesticides, and brominated flame retardants. Evidence indicates that EDCs may act through receptor-mediated signaling, altered hormone synthesis and metabolism, oxidative stress, mitochondrial dysfunction, immune modulation, and epigenetic mechanisms, with effects that may vary according to dose, timing, sex, age, and developmental susceptibility. Reported health outcomes include metabolic and cardiovascular disorders, reproductive dysfunction, hormone-dependent cancers, thyroid disruption, immune dysregulation, and adverse developmental effects. Although complete avoidance is unrealistic, exposure reduction and risk mitigation can be achieved through coordinated individual, clinical, environmental, and regulatory interventions. A life-course approach is essential to limit the health burden associated with endocrine disruption.